HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

desmedipham

structure

Also Known As:

ethyl m-hydroxycarbanilate carbanilate

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Carbamates: 945
      - desmedipham: 1

Experts

1.	Food Safety Commission of Japan: 1 article (09/2018)

Related Diseases

1.	Cleft Palate (Palate, Cleft) 09/01/2018 - "Desmedipham, at the dose with maternal toxicity, caused external anomalies such as mandibular malformation and cleft palate, visceral anomalies such as ventricular septum defect, and skeletal anomalies such as defect of sternum and asymmetric alignment of seternebral hemicentres in developmental toxicity studies in rats. "
2.	Methemoglobinemia 09/01/2018 - "Major adverse effects of desmedipham were suppressed body weight, hemolytic anemia, methemoglobinemia and follicular cell hypertrophy in thyroid. "
3.	Hypertrophy 09/01/2018 - "Major adverse effects of desmedipham were suppressed body weight, hemolytic anemia, methemoglobinemia and follicular cell hypertrophy in thyroid. "
4.	Body Weight (Weight, Body) 09/01/2018 - "Major adverse effects of desmedipham were suppressed body weight, hemolytic anemia, methemoglobinemia and follicular cell hypertrophy in thyroid. "
5.	Hemolytic Anemia 09/01/2018 - "Major adverse effects of desmedipham were suppressed body weight, hemolytic anemia, methemoglobinemia and follicular cell hypertrophy in thyroid. "